CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q3 2017
Shares 900 Value ($000) $3 Avg Close — Range —
Q1 2017
Shares 23,400 Value ($000) $98 Avg Close — Range —